Heat Shock Proteins in Behçet Syndrome


Journal

Balkan medical journal
ISSN: 2146-3131
Titre abrégé: Balkan Med J
Pays: Turkey
ID NLM: 101571817

Informations de publication

Date de publication:
11 09 2023
Historique:
medline: 13 9 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: ppublish

Résumé

Behçet syndrome (BS) is a systemic vasculitis of unknown etiology that affects the skin, mucosa, joints, eyes, central nervous system, gastrointestinal system, arteries, and veins. It is generally believed to have a complex genetic background where both innate and adaptive immune systems are activated through environmental factors, such as infections, and auto-antigens. Heat shock proteins (HSPs) are highly conserved and immunogenic endogenous proteins that are thought to play both an enhancing and regulating role in several autoimmune and inflammatory diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis, and Type I diabetes. There is evidence supporting the role of various microorganisms in BS, which may be using a common pathway to trigger or activate BS through molecular mimicry. The significant homology between microbial and human HSPs suggests that HSPs could serve as a common trigger. This review summarizes the work on the role of HSPs in the pathogenesis of BS. However, it remains unknown whether the HSPs detected in BS lesions play a causative role, their presence is a result of the ongoing inflammation, or they have a protective role against inflammation, as suggested in some other diseases.

Identifiants

pubmed: 37525514
doi: 10.4274/balkanmedj.galenos.2023.2023-6-76
pmc: PMC10500141
doi:

Substances chimiques

Heat-Shock Proteins 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

314-323

Références

Autoimmun Rev. 2009 Mar;8(5):388-93
pubmed: 19121415
Oral Microbiol Immunol. 2005 Jun;20(3):167-71
pubmed: 15836518
Lancet. 2003 Aug 9;362(9382):469-76
pubmed: 12927437
J Autoimmun. 2017 Nov;84:87-96
pubmed: 28844827
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7196-201
pubmed: 8692968
Microbiome. 2018 Aug 4;6(1):135
pubmed: 30077182
J Immunol. 1993 Aug 15;151(4):2273-82
pubmed: 7688396
Exp Eye Res. 1998 Dec;67(6):719-27
pubmed: 9990336
Rheumatol Int. 2007 Oct;27(12):1113-8
pubmed: 17549482
Ann Rheum Dis. 1993 Aug;52(8):619-20
pubmed: 8215629
Ann Rheum Dis. 1984 Dec;43(6):783-9
pubmed: 6524980
Med Sci Monit. 2018 Mar 13;24:1511-1516
pubmed: 29534057
Clin Immunol. 2016 Aug;169:28-35
pubmed: 27283393
Clin Exp Immunol. 1998 Jul;113(1):100-4
pubmed: 9697991
J Rheumatol. 2000 Mar;27(3):708-13
pubmed: 10743813
Ann Rheum Dis. 1989 May;48(5):421-3
pubmed: 2730167
Sci Rep. 2019 Aug 12;9(1):11716
pubmed: 31406212
J Immunol. 1977 Dec;119(6):1949-58
pubmed: 334977
J Oral Microbiol. 2015 Jun 01;7:27150
pubmed: 26037240
Clin Exp Immunol. 1998 May;112(2):317-24
pubmed: 9649197
Clin Exp Immunol. 2008 May;152(2):245-51
pubmed: 18336589
Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S96-8
pubmed: 19026123
Arthritis Rheum. 2009 Oct 15;61(10):1287-96
pubmed: 19790126
Arthritis Rheum. 2010 Jan;62(1):305-6
pubmed: 20039415
PeerJ. 2019 Jan 14;6:e6185
pubmed: 30656066
Lancet. 1996 Mar 23;347(9004):789-94
pubmed: 8622334
PLoS One. 2019 Sep 12;14(9):e0222384
pubmed: 31513650
Cell Immunol. 1992 Apr;140(2):410-9
pubmed: 1544169
Infect Immun. 1991 Apr;59(4):1434-41
pubmed: 2004821
Arthritis Rheum. 1996 Dec;39(12):2062-5
pubmed: 8961912
Eur J Immunol. 1998 Aug;28(8):2444-55
pubmed: 9710222
Immunol Lett. 2001 Dec 3;79(3):203-8
pubmed: 11600199
Clin Exp Immunol. 1994 Aug;97(2):226-31
pubmed: 7519530
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Aug;110(2):196-200
pubmed: 20580281
Cells. 2021 Oct 01;10(10):
pubmed: 34685607
J Am Acad Dermatol. 2001 Dec;45(6):904-9
pubmed: 11712037
Clin Exp Immunol. 1997 May;108(2):204-12
pubmed: 9158087
Arch Oral Biol. 1990;35(1):43-8
pubmed: 2117912
Eur J Dermatol. 2008 Sep-Oct;18(5):489-98
pubmed: 18693149
J Neurol. 2000 Dec;247(12):935-9
pubmed: 11200685
J Neuroimmunol. 2002 Sep;130(1-2):46-54
pubmed: 12225887
Dermatology. 1996;192(2):125-8
pubmed: 8829493
Eur J Immunol. 1994 Jul;24(7):1536-43
pubmed: 7517873
Clin Exp Rheumatol. 2004 Jul-Aug;22(4 Suppl 34):S59-63
pubmed: 15515788
Clin Exp Rheumatol. 1999 May-Jun;17(3):347-50
pubmed: 10410270
Clin Exp Rheumatol. 2003 Jul-Aug;21(4 Suppl 30):S44-8
pubmed: 14727460
Eur J Immunol. 2003 Jan;33(1):224-32
pubmed: 12594851
Microbiol Immunol. 1992;36(8):815-22
pubmed: 1474932
Rheumatology (Oxford). 2012 Jun;51(6):1053-60
pubmed: 22286924
Curr Eye Res. 1981;1(6):327-37
pubmed: 6975701
Int Rev Immunol. 1997;14(1):21-32
pubmed: 9203024
Br J Dermatol. 2007 Jan;156(1):32-7
pubmed: 17199563
Clin Exp Immunol. 2005 Feb;139(2):371-8
pubmed: 15654837
Scand J Immunol. 2013 Jun;77(6):476-81
pubmed: 23701436
J Dig Dis. 2018 Jun;19(6):350-358
pubmed: 29851304
J Vasc Surg. 1999 Apr;29(4):748-51
pubmed: 10194511
Scand J Rheumatol. 2017 Sep;46(5):381-387
pubmed: 28276957
J Lab Clin Med. 2003 Jan;141(1):33-40
pubmed: 12518166
Mol Cell Biol. 1989 May;9(5):2279-83
pubmed: 2568584
Ocul Immunol Inflamm. 2001 Jun;9(2):85-92
pubmed: 11449324
Ann Rheum Dis. 2004 Nov;63(11):1450-2
pubmed: 15479894
Scand J Immunol. 1996 Apr;43(4):464-71
pubmed: 8668927
Ocul Immunol Inflamm. 1998 Sep;6(3):139-44
pubmed: 9785603
Clin Exp Immunol. 2004 Jul;137(1):201-8
pubmed: 15196263
J Exp Med. 1999 Jan 18;189(2):279-88
pubmed: 9892610
J Immunol. 1990 Mar 1;144(5):1689-95
pubmed: 2137841
Int Immunol. 2000 Oct;12(10):1449-57
pubmed: 11007763
Br J Ophthalmol. 1993 Mar;77(3):171-5
pubmed: 8457510
Arthritis Rheum. 2008 May;58(5):1539-45
pubmed: 18438817
J Rheumatol. 2002 Nov;29(11):2393-6
pubmed: 12415598

Auteurs

Aslı Kıymet Kireçtepe Aydın (AK)

Department of Medical Biology, İstanbul Nişantaşı University Medical Faculty, İstanbul, Turkey

Gülen Hatemi (G)

Department of Internal Medicine, Division of Rheumatology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH